These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1428526)

  • 1. Degradation of aspartic acid and asparagine residues in human growth hormone-releasing factor.
    Bongers J; Heimer EP; Lambros T; Pan YC; Campbell RM; Felix AM
    Int J Pept Protein Res; 1992 Apr; 39(4):364-74. PubMed ID: 1428526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degradation of growth hormone releasing factor analogs in neutral aqueous solution is related to deamidation of asparagine residues. Replacement of asparagine residues by serine stabilizes.
    Friedman AR; Ichhpurani AK; Brown DM; Hillman RM; Krabill LF; Martin RA; Zurcher-Neely HA; Guido DM
    Int J Pept Protein Res; 1991 Jan; 37(1):14-20. PubMed ID: 1904406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution conformation of Leu27 hGRF(1-32)NH2 and its deamidation products by 2D NMR.
    Stevenson CL; Donlan ME; Friedman AR; Borchardt RT
    Int J Pept Protein Res; 1993 Jul; 42(1):24-32. PubMed ID: 8370640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced stability and potency of novel growth hormone-releasing factor (GRF) analogues derived from rodent and human GRF sequences.
    Campbell RM; Stricker P; Miller R; Bongers J; Liu W; Lambros T; Ahmad M; Felix AM; Heimer EP
    Peptides; 1994; 15(3):489-95. PubMed ID: 7937325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of dipeptidyl peptidase IV proteolysis of growth hormone-releasing factor and analogs.
    Bongers J; Lambros T; Ahmad M; Heimer EP
    Biochim Biophys Acta; 1992 Jul; 1122(2):147-53. PubMed ID: 1353684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro stability of growth hormone releasing factor (GRF) analogs in porcine plasma.
    Su CM; Jensen LR; Heimer EP; Felix AM; Pan YC; Mowles TF
    Horm Metab Res; 1991 Jan; 23(1):15-21. PubMed ID: 1826667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological activity and conformational analysis of cyclic GRF analogs.
    Felix AM; Heimer EP; Wang CT; Lambros TJ; Fournier A; Mowles TF; Maines S; Campbell RM; Wegrzynski BB; Toome V
    Int J Pept Protein Res; 1988 Dec; 32(6):441-54. PubMed ID: 3149952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of secondary structure on the rate of deamidation of several growth hormone releasing factor analogs.
    Stevenson CL; Friedman AR; Kubiak TM; Donlan ME; Borchardt RT
    Int J Pept Protein Res; 1993 Dec; 42(6):497-503. PubMed ID: 8307680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stability and degradation pathway of recombinant human parathyroid hormone: deamidation of asparaginyl residue and peptide bond cleavage at aspartyl and asparaginyl residues.
    Nabuchi Y; Fujiwara E; Kuboniwa H; Asoh Y; Ushio H
    Pharm Res; 1997 Dec; 14(12):1685-90. PubMed ID: 9453054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semisynthesis of human growth hormone-releasing factor by trypsin catalyzed coupling of leucine amide to a C-terminal acid precursor.
    Bongers J; Offord RE; Felix AM; Campbell RM; Heimer EP
    Int J Pept Protein Res; 1992; 40(3-4):268-73. PubMed ID: 1478784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical pathways of peptide degradation. IV. Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide.
    Oliyai C; Borchardt RT
    Pharm Res; 1993 Jan; 10(1):95-102. PubMed ID: 8430066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of N-terminal modifications on the biological potencies of growth hormone releasing factor analogues with varying chain lengths.
    Coy DH; Murphy WA; Lance VA; Heiman ML
    J Med Chem; 1987 Jan; 30(1):219-22. PubMed ID: 3100799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of receptor-binding pharmacophores of growth-hormone-releasing factor in rat adenopituitary.
    Lefrançois L; Gaudreau P
    Neuroendocrinology; 1994 Apr; 59(4):363-70. PubMed ID: 8202217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical pathways of peptide degradation. II. Kinetics of deamidation of an asparaginyl residue in a model hexapeptide.
    Patel K; Borchardt RT
    Pharm Res; 1990 Jul; 7(7):703-11. PubMed ID: 2395797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of separation and detection techniques for human growth hormone releasing factor (hGRF) and the products derived from deamidation.
    Stevenson CL; Anderegg RJ; Borchardt RT
    J Pharm Biomed Anal; 1993; 11(4-5):367-73. PubMed ID: 8357873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative rates of glutamine and asparagine deamidation in glucagon fragment 22-29 under acidic conditions.
    Joshi AB; Kirsch LE
    J Pharm Sci; 2002 Nov; 91(11):2331-45. PubMed ID: 12379918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of a histidine residue on the C-terminal side of an asparaginyl residue on the rate of deamidation using model pentapeptides.
    Goolcharran C; Stauffer LL; Cleland JL; Borchardt RT
    J Pharm Sci; 2000 Jun; 89(6):818-25. PubMed ID: 10824141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation.
    Geiger T; Clarke S
    J Biol Chem; 1987 Jan; 262(2):785-94. PubMed ID: 3805008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic and thermodynamic control of the relative yield of the deamidation of asparagine and isomerization of aspartic acid residues.
    Capasso S; Di Cerbo P
    J Pept Res; 2000 Dec; 56(6):382-7. PubMed ID: 11152297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acidic N + 1 residues on asparagine deamidation rates in solution and in the solid state.
    Li B; Gorman EM; Moore KD; Williams T; Schowen RL; Topp EM; Borchardt RT
    J Pharm Sci; 2005 Mar; 94(3):666-75. PubMed ID: 15668945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.